IP Library Granted Patent US 12,649,933
Granted Patent B2
US 12,649,933 · App. 18/007,178 · Granted Jun 9, 2026

Cells having gene duplications and uses thereof

Inventor: Lin Zhang (Union, NJ)
Assignee: Pfizer Inc.
C12N15/90
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,649,933
App. No.
18/007,178
Granted
Jun 9, 2026
Kind
B2
Abstract

Host cells having improved growth characteristics are provided. Also provided are methods of selecting, using, and making the cells.

Claims (35)

1 . A Chinese Hamster Ovary (CHO) mammalian host cell comprising an exogenous nucleic acid and a duplication of at least one gene selected from the group consisting of: Spire1, Nars, Rps14, Smim3, Fem1c, Ppic, Lmnb1, Me2, Pias2, Sh3rf2, Rnmt, and Sehl1,

wherein the Spirel gene encodes a polypeptide comprising the amino acid sequence of SEQ ID NO: 1; wherein the Nars gene encodes a polypeptide comprising the amino acid sequence of SEQ ID NO: 2; wherein the Rps14 gene encodes a polypeptide comprising the amino acid sequence of SEQ ID NO: 3; wherein the Smim3 gene encodes a polypeptide comprising the amino acid sequence of SEQ ID NO: 4; wherein the Fem 1c gene encodes a polypeptide comprising the amino acid sequence of SEQ ID NO: 5; wherein the Ppic gene encodes a polypeptide comprising the amino acid sequence of SEQ ID NO: 6; wherein the Lmnb 1 gene encodes a polypeptide comprising the amino acid sequence of SEQ ID NO: 7; wherein the Me2 gene encodes a polypeptide comprising the amino acid sequence of SEQ ID NO: 8; wherein the Pias2 gene encodes a polypeptide comprising the amino acid sequence of SEQ ID NO: 9; wherein the Sh3rf2 gene encodes a polypeptide comprising the amino acid sequence of SEQ ID NO: 10; and

wherein the host cell has an improved growth characteristic as compared to an otherwise identical host cell lacking duplication of the at least one gene.

2 . The CHO host cell of claim 1 , comprising a duplication of at least two genes, wherein one of the at least two gens is selected from the group consisting of: Spire1, Nars, Rps14, and Smim3, and one of the at least two genes is selected from the group consisting of: Fem1c, Ppic, Lmnb1, Me2, Pias2, and Sh3rf2.

3 . The CHO host cell of claim 1 , comprising a duplication of at least four genes:

wherein one of the at least four genes is selected from the group consisting of: Spire1, Nars, Rps14, and Smim3;

wherein one of the at least four genes is selected from the group consisting of: Fem1c, Ppic, and Lmnb1;

wherein one of the at least four genes is selected from the group consisting of: Me2 and Pias2; and

wherein one of the at least four genes is Sh3rf2.

4 . A method of selecting a Chinese Hamster Ovary (CHO) host cell having an improved growth characteristic, the method comprising:

(a) assaying a CHO host cell comprising an exogenous nucleic acid for duplication of at least one gene selected from the group consisting of: Spire1, Nars, Rps14, Smim3, Fem1c, Ppic, Lmnb1, Me2, Pias2, Sh3rf2, Rnmt, and Sehl1,

wherein the Spirel gene encodes a polypeptide comprising the amino acid sequence of SEQ ID NO: 1; wherein the Nars gene encodes a polypeptide comprising the amino acid sequence of SEQ ID NO: 2; wherein the Rps14 gene encodes a polypeptide comprising the amino acid sequence of SEQ ID NO: 3; wherein the Smim3 gene encodes a polypeptide comprising the amino acid sequence of SEQ ID NO: 4; wherein the Fem 1c gene encodes a polypeptide comprising the amino acid sequence of SEQ ID NO: 5; wherein the Ppic gene encodes a polypeptide comprising the amino acid sequence of SEQ ID NO: 6; wherein the Lmnb 1 gene encodes a polypeptide comprising the amino acid sequence of SEQ ID NO: 7; wherein the Me2 gene encodes a polypeptide comprising the amino acid sequence of SEQ ID NO: 8; wherein the Pias2 gene encodes a polypeptide comprising the amino acid sequence of SEQ ID NO: 9; wherein the Sh3rf2 gene encodes a polypeptide comprising the amino acid sequence of SEQ ID NO: 10; and

(b) selecting the CHO host cell comprising duplication of the at least one gene,

wherein the assaying step (a) comprises fluorescent in situ hybridization (FISH), comparative genomic hybridization, microarray based systems, whole genome sequencing or a combination thereof, and

wherein the CHO host cell comprising duplication of the at least one gene has an improved growth characteristic as compared to an otherwise identical CHO host cell lacking duplication of the at least one gene.

5 . The method of claim 4 , wherein the CHO host cell is assayed for duplication of at least two genes and wherein one of the at least two genes is selected from the group consisting of: Spire1, Nars, Rps14, Smim3, and one of the at least two genes is selected from the group consisting of: Fem1c, Ppic, Lmnb1, Me2, Pias2, and Sh3rf2.

6 . A method for producing a recombinant protein, the method comprising:

(a) providing the CHO host cell of claim 1 , wherein the exogenous nucleic acid of the host cell encodes a recombinant protein;

(b) culturing the CHO host cell under conditions sufficient to express the recombinant protein.

7 . A method for producing a recombinant protein, the method comprising:

(a) providing a CHO host cell selected according to the method of claim 4 , wherein the exogenous nucleic acid of the host cell encodes a recombinant protein;

(b) culturing the CHO host cell under conditions sufficient to express the recombinant protein.

8 . The method of claim 6 , further comprising recovering the expressed recombinant protein.

9 . The CHO host cell of claim 1 , wherein the exogenous nucleic acid encodes a protein.

10 . The CHO host cell of claim 9 , wherein the protein is an antibody or a cytokine.

11 . A method of preparing a Chinese Hamster Ovary (CHO) host cell having an improved growth characteristic, the method comprising:

introducing an exogenous nucleic acid molecule comprising the sequence of at least one gene selected from the group consisting of: Spire1, Nars, Rps14, Smim3, Fem1c, Ppic, Lmnb1, Me2, Pias2, Sh3rf2, Rnmt, and Sehl1l into the CHO host cell,

wherein the Spirel gene encodes a polypeptide comprising the amino acid sequence of SEQ ID NO: 1; wherein the Nars gene encodes a polypeptide comprising the amino acid sequence of SEQ ID NO: 2; wherein the Rps14 gene encodes a polypeptide comprising the amino acid sequence of SEQ ID NO: 3; wherein the Smim3 gene encodes a polypeptide comprising the amino acid sequence of SEQ ID NO: 4; wherein the Fem 1c gene encodes a polypeptide comprising the amino acid sequence of SEQ ID NO: 5; wherein the Ppic gene encodes a polypeptide comprising the amino acid sequence of SEQ ID NO: 6; wherein the Lmnb 1 gene encodes a polypeptide comprising the amino acid sequence of SEQ ID NO: 7; wherein the Me2 gene encodes a polypeptide comprising the amino acid sequence of SEQ ID NO: 8; wherein the Pias2 gene encodes a polypeptide comprising the amino acid sequence of SEQ ID NO: 9; wherein the Sh3rf2 gene encodes a polypeptide comprising the amino acid sequence of SEQ ID NO: 10; and

wherein the host cell comprising the exogenous nucleic acid molecule has an improved growth characteristic as compared to an otherwise identical CHO host cell that does not contain the exogenous nucleic acid molecule.

12 . The method of claim 11 , wherein one or more exogenous nucleic acid molecules comprising the sequence of at least two of the at least one genes are introduced into the host cell.

13 . The method of claim 12 , wherein one of the at least two genes is selected from the group consisting of: Spire1, Nars, Rps14, Smim3, and one of the at least two genes is selected from the group consisting of: Fem1c, Ppic, Lmnb1, Me2, Pias2, and Sh3rf2.

14 . The CHO host cell of claim 1 , wherein the exogenous nucleic acid is chromosomally-integrated in a host cell chromosome.

15 . The CHO host cell of claim 1 , wherein the improved growth characteristic is greater cell count, greater viable cell count, greater cell density, or greater viable cell density of a first cell culture comprising the cell having an improved growth characteristic as compared to a second cell culture comprising the otherwise identical CHO host cell lacking duplication of the gene(s), wherein the first and second cell cultures are grown under the same conditions and for the same time period.

16 . The method of claim 7 , further comprising recovering the recombinant protein.

17 . The method of claim 7 , wherein the exogenous nucleic acid encodes a protein and wherein the protein is an antibody or a cytokine.

Assignments (1)
ASSIGNEE ADDRESS CORRECTION Recorded Mar 20, 2023
From: PFIZER INC.
To: PFIZER INC.
Reel/Frame 063119/0087 →
Continuity (2)
Provisional Application 62706075 · Jul 30, 2020
Related Publication 20230287455A1 · Sep 14, 2023
References Cited (15)
JP 2016127817A · 2016 [cited by applicant]
WO 2007123489 · 2007 [cited by applicant]
WO 2022023972A1 · 2022 [cited by applicant]
GenBank LMNB1_Human. 2019. GenBank. 1-12. (Year: 2019). [cited by examiner]
Singh RK et al. Protein Engineering Approaches in the Post-Genomic Era. 2017. Current Protein and Peptide Science. 18, 1-11. (Year: 2017). [cited by examiner]
Zanigni S et al. Brain magnetic resonance metabolic and microstructural changes in adult-onset autosomal dominant leukodrystrophy. 2015. Brain Research Bulletin. 117, 14-31. (Year: 2015). [cited by examiner]
Zhang M et al. Propagated Perturbations from a Peripheral Mutation Show Interactions Supporting WW Domain Thermostability. 2018. Structure. 26, 1474-1485. (Year: 2018). [cited by examiner]
Mattanovich D et al: “Stress in recombinant protein producing yeasts”, Journal of Biotechnology, Elsevier, Amsterdam NL, vol. 113, No. 1-3, Sep. 30, 2004 (Sep. 30, 2004), pp. 121-135. [cited by applicant]
Wang Z et al: “Enhancement of therapeutic monoclonal antibody production in CHO cells using 30Kc6 gene”, Dec. 1, 2010 (Dec. 1, 2010), Process Biochemistry, Elsevier Ltd, GB, pp. 1852-1856. [cited by applicant]
Zhao X et al: “Overexpression of survivin and cyclin DI in CHO cells confers apoptosis resistance and enhances growth in serum-free suspension culture”, Biotechnology Letters, Springer Netherlands, Dordrecht, vol. 33, N… [cited by applicant]
Dhara, V.G., et al., “Recombinant Antibody Production in CHO and NSO Cells: Differences and Similarities,” BioDrugs, 2018, 32:571-584. [cited by applicant]
International Preliminary Report on Patentability issued in PCT/IB2021/056803; mailed on Feb. 9, 2023; 7 pp. [cited by applicant]
International Search Report issued in PCT/IB2021/056803; mailed on Oct. 27, 2021; 6 pp. [cited by applicant]
Trask, B.J. and Hamlin, J.L., “Early Dihydrofolate Reductase Gene Amplification Events in CHO Cells Usually Occur on the Same Chromosome Arm as the Original Locus,” Genes & Development, 1989, 3:1913-1925. [cited by applicant]
Written Opinion issued in PCT/IB2021/056803; mailed on Oct. 27, 2021; 5 pp. [cited by applicant]